Modified frailty index predicts complications and death after non-bariatric gastrectomies

Konstantinos A Zorbas1, Vic Velanovich2, Nestor F Esnaola3

  • 1Department of Surgery, Bronx Care Health System, New York, NY, USA.

Abstract

Insights

The modified frailty index (mFI) effectively predicts higher risks of complications and death after gastrectomy for non-bariatric conditions. This simple preoperative assessment aids in planning patient treatment strategies.

Area of Science:

  • Surgical oncology
  • Geriatric surgery
  • Patient outcomes research

Background:

  • The modified frailty index (mFI) is a validated tool for predicting mortality and morbidity post-major surgery.
  • Gastrectomy for non-bariatric conditions involves significant risks of complications and mortality.

Purpose of the Study:

  • To evaluate the modified frailty index (mFI) as a preoperative predictor of short-term postoperative complications.
  • To assess the mFI's ability to predict 30-day mortality in patients undergoing gastrectomy for non-bariatric diseases.

Main Methods:

  • Utilized the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database (2005-2011).
  • Calculated a modified frailty index (mFI) based on 11 variables.
  • Categorized patients into four groups: non-frail (mFI 0), low frail (mFI 1), intermediate frail (mFI 2), and frail (mFI ≥3).

Main Results:

  • Higher mFI scores correlated with increased rates of 30-day mortality (1.2% to 10.7%).
  • Significant associations found between higher mFI and increased overall morbidity (26.7% vs. 51.1%), severe complications (Clavien IV: 6% vs. 24.6%), and failure to rescue (5.7% vs. 21.8%).
  • Elevated mFI scores were linked to higher rates of sepsis-related and cardiopulmonary complications.

Conclusions:

  • The modified frailty index (mFI) demonstrates a clear, stepwise increase in postoperative morbidity and mortality risk for patients undergoing non-bariatric gastrectomy.
  • The mFI is a practical, easily calculable preoperative tool for risk stratification and treatment planning in gastrectomy patients.